|
⚲
|
| Keyboard |
| Lamattina John L
✚
|
|
|---|---|
| CIK # | 0001216074 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001216074] | |
| 4 | [0001216074] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lamattina John L | |
| Ligand Pharmaceuticals Inc | |
| Immunome Inc | |
| Zafgen Inc | |
| Human Genome Sciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-06 | Option exercise | 2,161 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-06 | Sell | 2,161 | $200.76 | 433,842 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-06 | Option exercise | 2,161 | $114.15 | 246,678 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-11-07 | Sell | 2,034 | $205.45 | 417,885 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-11-07 | Option exercise | 2,145 | $66.13 | 141,849 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-11-07 | Sell | 2,145 | $205.45 | 440,690 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-11-07 | Option exercise | 2,034 | $69.51 | 141,383 |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-11-07 | Option exercise | 2,145 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-11-07 | Option exercise | 2,034 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-06-06 | Grant | 1,209 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-06 | Grant | 5,783 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-11-27 | Sell | 2,406 | $123.65 | 297,502 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-11-27 | Option exercise | 2,406 | $52.30 | 125,834 |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2024-11-27 | Option exercise | 2,406 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-06-14 | Grant | 1,252 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2024-06-14 | Grant | 5,444 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2023-06-09 | Grant | 1,142 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2023-06-09 | Grant | 5,461 | $0.00 | |
|
Immunome Inc IMNM
Stock Option (Right to Buy) · derivative
|
2023-06-08 | Grant | 6,500 | $0.00 | |
|
Immunome Inc IMNM
Common Stock
|
2023-01-15 | Grant | 15,125 | $4.00 | 60,500 |
| showing 20 of 97 most recent transactions | |||||